S&P 500   4,356.45
DOW   34,297.73
QQQ   345.11
S&P 500   4,356.45
DOW   34,297.73
QQQ   345.11
S&P 500   4,356.45
DOW   34,297.73
QQQ   345.11
S&P 500   4,356.45
DOW   34,297.73
QQQ   345.11
NASDAQ:MTP

Midatech Pharma Stock Forecast, Price & News

$1.01
+0.01 (+1.00%)
(As of 01/25/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.94
$1.05
50-Day Range
$1.00
$1.66
52-Week Range
$0.88
$3.83
Volume
64,598 shs
Average Volume
87,789 shs
Market Capitalization
$12.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.51
30 days | 90 days | 365 days | Advanced Chart
Receive MTP News and Ratings via Email

Sign-up to receive the latest news and ratings for Midatech Pharma and its competitors with MarketBeat's FREE daily newsletter.


Midatech Pharma logo

About Midatech Pharma

Midatech Pharma Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in house programmes as well as partnered programmes. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is a innovative nanosaccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is a edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale ie i. chemotherapy - improved and targeted delivery of existing chemotherapeutic agents to tumor sites, as well as ii. immunotherapy - enhanced uptake of new immuno-moieties by immune cells that can then mount an immune attack against cancer cells. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MTP
Fax
N/A
Employees
2,020
Year Founded
N/A

Sales & Book Value

Annual Sales
$440 thousand
Book Value
$0.68 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$12.80 million
Optionable
Not Optionable

Company Calendar

Today
1/26/2022
Next Earnings (Estimated)
4/29/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.00 out of 5 stars

Medical Sector

1272nd out of 1,416 stocks

Pharmaceutical Preparations Industry

617th out of 684 stocks

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Midatech Pharma (NASDAQ:MTP) Frequently Asked Questions

How has Midatech Pharma's stock price been impacted by Coronavirus (COVID-19)?

Midatech Pharma's stock was trading at $3.12 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MTP shares have decreased by 67.6% and is now trading at $1.01.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Midatech Pharma?

Midatech Pharma saw a drop in short interest during the month of December. As of December 31st, there was short interest totaling 33,500 shares, a drop of 83.7% from the December 15th total of 205,800 shares. Based on an average trading volume of 137,800 shares, the days-to-cover ratio is presently 0.2 days.
View Midatech Pharma's Short Interest
.

When is Midatech Pharma's next earnings date?

Midatech Pharma is scheduled to release its next quarterly earnings announcement on Friday, April 29th 2022.
View our earnings forecast for Midatech Pharma
.

Who are Midatech Pharma's key executives?

Midatech Pharma's management team includes the following people:
  • Stephen Anthony Stamp, Director, Chief Executive & Financial Officer
  • Dmitry Zamoryakhin, Chief Scientific Officer
  • Fiona Sharp, Group Financial Controller

What other stocks do shareholders of Midatech Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Midatech Pharma investors own include CRISPR Therapeutics (CRSP), Corbus Pharmaceuticals (CRBP), Pfizer (PFE), Vaxart (VXRT), Nabriva Therapeutics (NBRV), Novavax (NVAX), Plug Power (PLUG), SCYNEXIS (SCYX), Sangamo Therapeutics (SGMO) and Sorrento Therapeutics (SRNE).

What is Midatech Pharma's stock symbol?

Midatech Pharma trades on the NASDAQ under the ticker symbol "MTP."

How do I buy shares of Midatech Pharma?

Shares of MTP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Midatech Pharma's stock price today?

One share of MTP stock can currently be purchased for approximately $1.01.

How much money does Midatech Pharma make?

Midatech Pharma has a market capitalization of $12.80 million and generates $440 thousand in revenue each year.

How many employees does Midatech Pharma have?

Midatech Pharma employs 2,020 workers across the globe.

What is Midatech Pharma's official website?

The official website for Midatech Pharma is www.midatechpharma.com.

Where are Midatech Pharma's headquarters?

Midatech Pharma is headquartered at ODDFELLOWS HOUSE 19 NEWPORT ROAD, CARDIFF X0, CF24 0AA.

How can I contact Midatech Pharma?

Midatech Pharma's mailing address is ODDFELLOWS HOUSE 19 NEWPORT ROAD, CARDIFF X0, CF24 0AA. The company can be reached via phone at 441235888300 or via email at [email protected].


This page was last updated on 1/26/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.